Journal
JAPANESE DENTAL SCIENCE REVIEW
Volume 55, Issue 1, Pages 95-102Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jdsr.2018.09.002
Keywords
BRONJ; Osteomyelitis; Osteonecrosis; Bisphosphonates; Jaw; Tooth extraction
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology (MEXT)
Ask authors/readers for more resources
Bisphosphonate-related osteonecrosis of the jaw (BRONJ), characterized by refractory bone exposure, has recently emerged as a serious side effect of bisphosphonate (BPs) treatment. We discuss novel insights that may help to improve the efficacy of BRONJ treatment and prevention. Our report highlights the following: (1) The presence of exposed bone in patients taking BPs does not necessarily reflect BRONJ, and diagnoses of oral ulceration with bone sequestration and malignancy must be excluded. (2) Osteonecrosis type of BRONJ is difficult to avoid using preventive dental measures alone. However, as with osteomyelitis type of BRONJ, preventive dental measures are indispensable for reducing the risk of secondary infection and disease progression. (3) The importance of tooth extraction as a risk factor for BRONJ among patients taking BPs has been overstated, particularly when they are administered at low doses. Delaying tooth extraction may increase the risk for the onset and progression of osteomyelitic BRONJ. (4) In patients taking low doses of BPs, dental implant surgery is not necessarily contraindicated if there are no other risk factors, such as combined use of corticosteroids or concomitant diabetes. However, the risk of BRONJ due to peri-implantitis must be explained when obtaining patient consent. (C) 2019 Published by Elsevier Ltd on behalf of The Japanese Association for Dental Science
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available